ExPASy Home page |
Site Map | Search ExPASy | Contact us |
| This database was originally developed by the Glaxo (now GSK) group at SIB. It is no longer maintained and has not been updated since 1996. However, the information provided by CD40Lbase continues to be valid. A much more up-to-date database is available. |
Structural aspects of CD40L
Reference 1: RA M. C. Peitsch & C. V. Jongeneel. RT "A 3-dimensional model for the cd40 ligand predicts that it is a compact RT trimer similar to the tumor necrosis factors" RL INT IMMUNOL 5:233-238 (1993) MEDLINE: 93200072. Reference 2: RA J. Bajorath, R. Stenkamp & A. Aruffo. RT "Knowledge-based model building of proteins: concepts and examples." RL Protein Sci 2:1798-1810(1993) MEDLINE: 94093388. Reference 3: RA Karpsusas M., Hsu Y.-M., Wang J.-H., Thompson J., Lederman S., RA CHESS L., THOMAS D.; RT "2A crystal structure of an extracellular fragment of human CD40 ligand." RL STRUCTURE 3:1031-1039(1995). Reference 4: RA M. C. Peitsch & J. Tschopp. RT "Comparative molecular modelling of the Fas-ligand andother members of RT the TNF family." RL MOL IMMUNOL 32:761-772 (1995) MEDLINE: 95388076. Reference 5: RA M. Hahne, M. C. Peitsch, M. Irmler, M. Schroter, B. Lowin, M. Rousseau, RA C. Bron, T. Renno, L. French & J. Tschopp. RT "Characterization of the non-functional Fas ligand of gldmice." RL INT IMMUNOL 7:1381-1386(1995) MEDLINE: 96091792. Reference 6: RA J. Bajorath, J. S. Marken, N. J. Chalupny, T. L. Spoon, A. W. Siadak, RA M. Gordon, R. J. Noelle, D.Hollenbaugh & A. Aruffo. RT "Analysis of gp39/CD40 interactions using molecular models and RT site-directed mutagenesis." RL Biochemistry 34:9884-9892(1995) MEDLINE: 95002262.
ExPASy Home page |
Site Map | Search ExPASy | Contact us |
| Hosted by | Mirror sites: | Australia | Brazil | China | Korea | Switzerland |